Global Point-of-care Testing (POCT) for Tumor Marker Supply, Demand and Key Producers, 2023-2029
The global Point-of-care Testing (POCT) for Tumor Marker market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Point-of-care Testing (POCT) for Tumor Marker production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Tumor Marker, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Tumor Marker that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Tumor Marker total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Tumor Marker production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Tumor Marker domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Tumor Marker production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Tumor Marker market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BioMerieux, Wondfo Biotech, Yuwell, Getein Biotech, Beijing Wantai BioPharm, Assure Tech and Randox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Tumor Marker market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Tumor Marker Market, By Region:
1. How big is the global Point-of-care Testing (POCT) for Tumor Marker market?
2. What is the demand of the global Point-of-care Testing (POCT) for Tumor Marker market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Tumor Marker market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Tumor Marker market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Tumor Marker market?
6. What are the growth factors driving the market demand?
This report studies the global Point-of-care Testing (POCT) for Tumor Marker production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Point-of-care Testing (POCT) for Tumor Marker, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Point-of-care Testing (POCT) for Tumor Marker that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Point-of-care Testing (POCT) for Tumor Marker total production and demand, 2018-2029, (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker total production value, 2018-2029, (USD Million)
Global Point-of-care Testing (POCT) for Tumor Marker production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Point-of-care Testing (POCT) for Tumor Marker domestic production, consumption, key domestic manufacturers and share
Global Point-of-care Testing (POCT) for Tumor Marker production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Point-of-care Testing (POCT) for Tumor Marker production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Point-of-care Testing (POCT) for Tumor Marker market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BioMerieux, Wondfo Biotech, Yuwell, Getein Biotech, Beijing Wantai BioPharm, Assure Tech and Randox, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Point-of-care Testing (POCT) for Tumor Marker market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Point-of-care Testing (POCT) for Tumor Marker Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Based on Immunochromatography
- Based on Chemiluminescence Technology
- Based on Biosensor
- Others
- Hospital
- lndependent Testing Organization
- Roche
- Abbott
- BioMerieux
- Wondfo Biotech
- Yuwell
- Getein Biotech
- Beijing Wantai BioPharm
- Assure Tech
- Randox
- Orient Gene
- Hangzhou Biotest
- Shenzhen YHLO
- Qingdao Hightop Biotech Co., Ltd.
- Getein Biotech, Inc.
- Wuhan Easy Diagnosis Biomedicine Co.,ltd.
1. How big is the global Point-of-care Testing (POCT) for Tumor Marker market?
2. What is the demand of the global Point-of-care Testing (POCT) for Tumor Marker market?
3. What is the year over year growth of the global Point-of-care Testing (POCT) for Tumor Marker market?
4. What is the production and production value of the global Point-of-care Testing (POCT) for Tumor Marker market?
5. Who are the key producers in the global Point-of-care Testing (POCT) for Tumor Marker market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Point-of-care Testing (POCT) for Tumor Marker Introduction
1.2 World Point-of-care Testing (POCT) for Tumor Marker Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Tumor Marker Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Tumor Marker Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Tumor Marker Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Tumor Marker Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Tumor Marker Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Tumor Marker Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR TUMOR MARKER MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Tumor Marker Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Tumor Marker Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Tumor Marker Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Tumor Marker in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Tumor Marker in 2022
3.6 Point-of-care Testing (POCT) for Tumor Marker Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Tumor Marker Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Tumor Marker Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Immunochromatography
5.2.2 Based on Chemiluminescence Technology
5.2.3 Based on Biosensor
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Tumor Marker Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 lndependent Testing Organization
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.2.4 Abbott Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.3.4 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Wondfo Biotech
7.4.1 Wondfo Biotech Details
7.4.2 Wondfo Biotech Major Business
7.4.3 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.4.4 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Wondfo Biotech Recent Developments/Updates
7.4.6 Wondfo Biotech Competitive Strengths & Weaknesses
7.5 Yuwell
7.5.1 Yuwell Details
7.5.2 Yuwell Major Business
7.5.3 Yuwell Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.5.4 Yuwell Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Yuwell Recent Developments/Updates
7.5.6 Yuwell Competitive Strengths & Weaknesses
7.6 Getein Biotech
7.6.1 Getein Biotech Details
7.6.2 Getein Biotech Major Business
7.6.3 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.6.4 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Getein Biotech Recent Developments/Updates
7.6.6 Getein Biotech Competitive Strengths & Weaknesses
7.7 Beijing Wantai BioPharm
7.7.1 Beijing Wantai BioPharm Details
7.7.2 Beijing Wantai BioPharm Major Business
7.7.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.7.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Wantai BioPharm Recent Developments/Updates
7.7.6 Beijing Wantai BioPharm Competitive Strengths & Weaknesses
7.8 Assure Tech
7.8.1 Assure Tech Details
7.8.2 Assure Tech Major Business
7.8.3 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.8.4 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Assure Tech Recent Developments/Updates
7.8.6 Assure Tech Competitive Strengths & Weaknesses
7.9 Randox
7.9.1 Randox Details
7.9.2 Randox Major Business
7.9.3 Randox Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.9.4 Randox Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Randox Recent Developments/Updates
7.9.6 Randox Competitive Strengths & Weaknesses
7.10 Orient Gene
7.10.1 Orient Gene Details
7.10.2 Orient Gene Major Business
7.10.3 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.10.4 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Orient Gene Recent Developments/Updates
7.10.6 Orient Gene Competitive Strengths & Weaknesses
7.11 Hangzhou Biotest
7.11.1 Hangzhou Biotest Details
7.11.2 Hangzhou Biotest Major Business
7.11.3 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.11.4 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Hangzhou Biotest Recent Developments/Updates
7.11.6 Hangzhou Biotest Competitive Strengths & Weaknesses
7.12 Shenzhen YHLO
7.12.1 Shenzhen YHLO Details
7.12.2 Shenzhen YHLO Major Business
7.12.3 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.12.4 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Shenzhen YHLO Recent Developments/Updates
7.12.6 Shenzhen YHLO Competitive Strengths & Weaknesses
7.13 Qingdao Hightop Biotech Co., Ltd.
7.13.1 Qingdao Hightop Biotech Co., Ltd. Details
7.13.2 Qingdao Hightop Biotech Co., Ltd. Major Business
7.13.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.13.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
7.13.6 Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.14 Getein Biotech, Inc.
7.14.1 Getein Biotech, Inc. Details
7.14.2 Getein Biotech, Inc. Major Business
7.14.3 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.14.4 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Getein Biotech, Inc. Recent Developments/Updates
7.14.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
7.15 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
7.15.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
7.15.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
7.15.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.15.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
7.15.6 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Tumor Marker Industry Chain
8.2 Point-of-care Testing (POCT) for Tumor Marker Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Tumor Marker Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Tumor Marker Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Tumor Marker Production Mode
8.6 Point-of-care Testing (POCT) for Tumor Marker Procurement Model
8.7 Point-of-care Testing (POCT) for Tumor Marker Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Tumor Marker Sales Model
8.7.2 Point-of-care Testing (POCT) for Tumor Marker Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Point-of-care Testing (POCT) for Tumor Marker Introduction
1.2 World Point-of-care Testing (POCT) for Tumor Marker Supply & Forecast
1.2.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value (2018 & 2022 & 2029)
1.2.2 World Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.2.3 World Point-of-care Testing (POCT) for Tumor Marker Pricing Trends (2018-2029)
1.3 World Point-of-care Testing (POCT) for Tumor Marker Production by Region (Based on Production Site)
1.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018-2029)
1.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2018-2029)
1.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2018-2029)
1.3.4 North America Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.5 Europe Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.6 China Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.3.7 Japan Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Point-of-care Testing (POCT) for Tumor Marker Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Point-of-care Testing (POCT) for Tumor Marker Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Point-of-care Testing (POCT) for Tumor Marker Demand (2018-2029)
2.2 World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region
2.2.1 World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region (2018-2023)
2.2.2 World Point-of-care Testing (POCT) for Tumor Marker Consumption Forecast by Region (2024-2029)
2.3 United States Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.4 China Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.5 Europe Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.6 Japan Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.7 South Korea Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.8 ASEAN Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
2.9 India Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029)
3 WORLD POINT-OF-CARE TESTING (POCT) FOR TUMOR MARKER MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Manufacturer (2018-2023)
3.2 World Point-of-care Testing (POCT) for Tumor Marker Production by Manufacturer (2018-2023)
3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Manufacturer (2018-2023)
3.4 Point-of-care Testing (POCT) for Tumor Marker Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Point-of-care Testing (POCT) for Tumor Marker Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Tumor Marker in 2022
3.5.3 Global Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Tumor Marker in 2022
3.6 Point-of-care Testing (POCT) for Tumor Marker Market: Overall Company Footprint Analysis
3.6.1 Point-of-care Testing (POCT) for Tumor Marker Market: Region Footprint
3.6.2 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Type Footprint
3.6.3 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison
4.1.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Comparison
4.2.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison
4.3.1 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.4.3 United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
4.5 China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share
4.5.1 China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.5.3 China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
4.6 Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Point-of-care Testing (POCT) for Tumor Marker Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Based on Immunochromatography
5.2.2 Based on Chemiluminescence Technology
5.2.3 Based on Biosensor
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2018-2029)
5.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2018-2029)
5.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Point-of-care Testing (POCT) for Tumor Marker Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 lndependent Testing Organization
6.3 Market Segment by Application
6.3.1 World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2018-2029)
6.3.2 World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2018-2029)
6.3.3 World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.1.4 Roche Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.2.4 Abbott Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.3.4 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Wondfo Biotech
7.4.1 Wondfo Biotech Details
7.4.2 Wondfo Biotech Major Business
7.4.3 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.4.4 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Wondfo Biotech Recent Developments/Updates
7.4.6 Wondfo Biotech Competitive Strengths & Weaknesses
7.5 Yuwell
7.5.1 Yuwell Details
7.5.2 Yuwell Major Business
7.5.3 Yuwell Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.5.4 Yuwell Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Yuwell Recent Developments/Updates
7.5.6 Yuwell Competitive Strengths & Weaknesses
7.6 Getein Biotech
7.6.1 Getein Biotech Details
7.6.2 Getein Biotech Major Business
7.6.3 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.6.4 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Getein Biotech Recent Developments/Updates
7.6.6 Getein Biotech Competitive Strengths & Weaknesses
7.7 Beijing Wantai BioPharm
7.7.1 Beijing Wantai BioPharm Details
7.7.2 Beijing Wantai BioPharm Major Business
7.7.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.7.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Beijing Wantai BioPharm Recent Developments/Updates
7.7.6 Beijing Wantai BioPharm Competitive Strengths & Weaknesses
7.8 Assure Tech
7.8.1 Assure Tech Details
7.8.2 Assure Tech Major Business
7.8.3 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.8.4 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Assure Tech Recent Developments/Updates
7.8.6 Assure Tech Competitive Strengths & Weaknesses
7.9 Randox
7.9.1 Randox Details
7.9.2 Randox Major Business
7.9.3 Randox Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.9.4 Randox Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Randox Recent Developments/Updates
7.9.6 Randox Competitive Strengths & Weaknesses
7.10 Orient Gene
7.10.1 Orient Gene Details
7.10.2 Orient Gene Major Business
7.10.3 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.10.4 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Orient Gene Recent Developments/Updates
7.10.6 Orient Gene Competitive Strengths & Weaknesses
7.11 Hangzhou Biotest
7.11.1 Hangzhou Biotest Details
7.11.2 Hangzhou Biotest Major Business
7.11.3 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.11.4 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Hangzhou Biotest Recent Developments/Updates
7.11.6 Hangzhou Biotest Competitive Strengths & Weaknesses
7.12 Shenzhen YHLO
7.12.1 Shenzhen YHLO Details
7.12.2 Shenzhen YHLO Major Business
7.12.3 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.12.4 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Shenzhen YHLO Recent Developments/Updates
7.12.6 Shenzhen YHLO Competitive Strengths & Weaknesses
7.13 Qingdao Hightop Biotech Co., Ltd.
7.13.1 Qingdao Hightop Biotech Co., Ltd. Details
7.13.2 Qingdao Hightop Biotech Co., Ltd. Major Business
7.13.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.13.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
7.13.6 Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
7.14 Getein Biotech, Inc.
7.14.1 Getein Biotech, Inc. Details
7.14.2 Getein Biotech, Inc. Major Business
7.14.3 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.14.4 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Getein Biotech, Inc. Recent Developments/Updates
7.14.6 Getein Biotech, Inc. Competitive Strengths & Weaknesses
7.15 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
7.15.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
7.15.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
7.15.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
7.15.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
7.15.6 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Point-of-care Testing (POCT) for Tumor Marker Industry Chain
8.2 Point-of-care Testing (POCT) for Tumor Marker Upstream Analysis
8.2.1 Point-of-care Testing (POCT) for Tumor Marker Core Raw Materials
8.2.2 Main Manufacturers of Point-of-care Testing (POCT) for Tumor Marker Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Point-of-care Testing (POCT) for Tumor Marker Production Mode
8.6 Point-of-care Testing (POCT) for Tumor Marker Procurement Model
8.7 Point-of-care Testing (POCT) for Tumor Marker Industry Sales Model and Sales Channels
8.7.1 Point-of-care Testing (POCT) for Tumor Marker Sales Model
8.7.2 Point-of-care Testing (POCT) for Tumor Marker Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Tumor Marker Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Tumor Marker Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Tumor Marker Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Tumor Marker Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Tumor Marker Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Tumor Marker Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Tumor Marker Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Tumor Marker Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Tumor Marker Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Tumor Marker Competitive Factors
Table 27. Point-of-care Testing (POCT) for Tumor Marker New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Tumor Marker Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Tumor Marker Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 70. Abbott Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 74. BioMerieux Major Business
Table 75. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 76. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BioMerieux Recent Developments/Updates
Table 78. BioMerieux Competitive Strengths & Weaknesses
Table 79. Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 80. Wondfo Biotech Major Business
Table 81. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 82. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Wondfo Biotech Recent Developments/Updates
Table 84. Wondfo Biotech Competitive Strengths & Weaknesses
Table 85. Yuwell Basic Information, Manufacturing Base and Competitors
Table 86. Yuwell Major Business
Table 87. Yuwell Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 88. Yuwell Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yuwell Recent Developments/Updates
Table 90. Yuwell Competitive Strengths & Weaknesses
Table 91. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Getein Biotech Major Business
Table 93. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 94. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Getein Biotech Recent Developments/Updates
Table 96. Getein Biotech Competitive Strengths & Weaknesses
Table 97. Beijing Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Wantai BioPharm Major Business
Table 99. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 100. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Wantai BioPharm Recent Developments/Updates
Table 102. Beijing Wantai BioPharm Competitive Strengths & Weaknesses
Table 103. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 104. Assure Tech Major Business
Table 105. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 106. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Assure Tech Recent Developments/Updates
Table 108. Assure Tech Competitive Strengths & Weaknesses
Table 109. Randox Basic Information, Manufacturing Base and Competitors
Table 110. Randox Major Business
Table 111. Randox Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 112. Randox Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Randox Recent Developments/Updates
Table 114. Randox Competitive Strengths & Weaknesses
Table 115. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 116. Orient Gene Major Business
Table 117. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 118. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Orient Gene Recent Developments/Updates
Table 120. Orient Gene Competitive Strengths & Weaknesses
Table 121. Hangzhou Biotest Basic Information, Manufacturing Base and Competitors
Table 122. Hangzhou Biotest Major Business
Table 123. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 124. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Hangzhou Biotest Recent Developments/Updates
Table 126. Hangzhou Biotest Competitive Strengths & Weaknesses
Table 127. Shenzhen YHLO Basic Information, Manufacturing Base and Competitors
Table 128. Shenzhen YHLO Major Business
Table 129. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 130. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Shenzhen YHLO Recent Developments/Updates
Table 132. Shenzhen YHLO Competitive Strengths & Weaknesses
Table 133. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Qingdao Hightop Biotech Co., Ltd. Major Business
Table 135. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 136. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 138. Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Getein Biotech, Inc. Major Business
Table 141. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 142. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Getein Biotech, Inc. Recent Developments/Updates
Table 144. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 145. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 146. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 147. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Point-of-care Testing (POCT) for Tumor Marker Upstream (Raw Materials)
Table 149. Point-of-care Testing (POCT) for Tumor Marker Typical Customers
Table 150. Point-of-care Testing (POCT) for Tumor Marker Typical Distributors
Table 1. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2018-2023) & (USD Million)
Table 3. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Region (2024-2029) & (USD Million)
Table 4. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2018-2023)
Table 5. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2024-2029)
Table 6. World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2018-2023) & (K Units)
Table 7. World Point-of-care Testing (POCT) for Tumor Marker Production by Region (2024-2029) & (K Units)
Table 8. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2018-2023)
Table 9. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2024-2029)
Table 10. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Point-of-care Testing (POCT) for Tumor Marker Major Market Trends
Table 13. World Point-of-care Testing (POCT) for Tumor Marker Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Point-of-care Testing (POCT) for Tumor Marker Consumption by Region (2018-2023) & (K Units)
Table 15. World Point-of-care Testing (POCT) for Tumor Marker Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Point-of-care Testing (POCT) for Tumor Marker Producers in 2022
Table 18. World Point-of-care Testing (POCT) for Tumor Marker Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Point-of-care Testing (POCT) for Tumor Marker Producers in 2022
Table 20. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Point-of-care Testing (POCT) for Tumor Marker Company Evaluation Quadrant
Table 22. World Point-of-care Testing (POCT) for Tumor Marker Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Point-of-care Testing (POCT) for Tumor Marker Production Site of Key Manufacturer
Table 24. Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Type Footprint
Table 25. Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Application Footprint
Table 26. Point-of-care Testing (POCT) for Tumor Marker Competitive Factors
Table 27. Point-of-care Testing (POCT) for Tumor Marker New Entrant and Capacity Expansion Plans
Table 28. Point-of-care Testing (POCT) for Tumor Marker Mergers & Acquisitions Activity
Table 29. United States VS China Point-of-care Testing (POCT) for Tumor Marker Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Point-of-care Testing (POCT) for Tumor Marker Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Point-of-care Testing (POCT) for Tumor Marker Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 37. China Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 42. Rest of World Based Point-of-care Testing (POCT) for Tumor Marker Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share (2018-2023)
Table 47. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2018-2023) & (K Units)
Table 49. World Point-of-care Testing (POCT) for Tumor Marker Production by Type (2024-2029) & (K Units)
Table 50. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2018-2023) & (USD Million)
Table 51. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type (2024-2029) & (USD Million)
Table 52. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2018-2023) & (K Units)
Table 56. World Point-of-care Testing (POCT) for Tumor Marker Production by Application (2024-2029) & (K Units)
Table 57. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2018-2023) & (USD Million)
Table 58. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application (2024-2029) & (USD Million)
Table 59. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Major Business
Table 63. Roche Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 64. Roche Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Roche Recent Developments/Updates
Table 66. Roche Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 70. Abbott Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 74. BioMerieux Major Business
Table 75. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 76. BioMerieux Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BioMerieux Recent Developments/Updates
Table 78. BioMerieux Competitive Strengths & Weaknesses
Table 79. Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 80. Wondfo Biotech Major Business
Table 81. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 82. Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Wondfo Biotech Recent Developments/Updates
Table 84. Wondfo Biotech Competitive Strengths & Weaknesses
Table 85. Yuwell Basic Information, Manufacturing Base and Competitors
Table 86. Yuwell Major Business
Table 87. Yuwell Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 88. Yuwell Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Yuwell Recent Developments/Updates
Table 90. Yuwell Competitive Strengths & Weaknesses
Table 91. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Getein Biotech Major Business
Table 93. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 94. Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Getein Biotech Recent Developments/Updates
Table 96. Getein Biotech Competitive Strengths & Weaknesses
Table 97. Beijing Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 98. Beijing Wantai BioPharm Major Business
Table 99. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 100. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Beijing Wantai BioPharm Recent Developments/Updates
Table 102. Beijing Wantai BioPharm Competitive Strengths & Weaknesses
Table 103. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 104. Assure Tech Major Business
Table 105. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 106. Assure Tech Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Assure Tech Recent Developments/Updates
Table 108. Assure Tech Competitive Strengths & Weaknesses
Table 109. Randox Basic Information, Manufacturing Base and Competitors
Table 110. Randox Major Business
Table 111. Randox Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 112. Randox Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Randox Recent Developments/Updates
Table 114. Randox Competitive Strengths & Weaknesses
Table 115. Orient Gene Basic Information, Manufacturing Base and Competitors
Table 116. Orient Gene Major Business
Table 117. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 118. Orient Gene Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Orient Gene Recent Developments/Updates
Table 120. Orient Gene Competitive Strengths & Weaknesses
Table 121. Hangzhou Biotest Basic Information, Manufacturing Base and Competitors
Table 122. Hangzhou Biotest Major Business
Table 123. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 124. Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Hangzhou Biotest Recent Developments/Updates
Table 126. Hangzhou Biotest Competitive Strengths & Weaknesses
Table 127. Shenzhen YHLO Basic Information, Manufacturing Base and Competitors
Table 128. Shenzhen YHLO Major Business
Table 129. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 130. Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Shenzhen YHLO Recent Developments/Updates
Table 132. Shenzhen YHLO Competitive Strengths & Weaknesses
Table 133. Qingdao Hightop Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Qingdao Hightop Biotech Co., Ltd. Major Business
Table 135. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 136. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 138. Qingdao Hightop Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 139. Getein Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 140. Getein Biotech, Inc. Major Business
Table 141. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 142. Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Getein Biotech, Inc. Recent Developments/Updates
Table 144. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 145. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 146. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
Table 147. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Point-of-care Testing (POCT) for Tumor Marker Upstream (Raw Materials)
Table 149. Point-of-care Testing (POCT) for Tumor Marker Typical Customers
Table 150. Point-of-care Testing (POCT) for Tumor Marker Typical Distributors
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Tumor Marker Picture
Figure 2. World Point-of-care Testing (POCT) for Tumor Marker Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Tumor Marker Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Tumor Marker Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Tumor Marker Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Tumor Marker by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Tumor Marker Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Tumor Marker Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Type in 2022
Figure 34. Based on Immunochromatography
Figure 35. Based on Chemiluminescence Technology
Figure 36. Based on Biosensor
Figure 37. Others
Figure 38. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Type (2018-2029)
Figure 39. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Type (2018-2029)
Figure 40. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. lndependent Testing Organization
Figure 45. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Application (2018-2029)
Figure 46. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Application (2018-2029)
Figure 47. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Point-of-care Testing (POCT) for Tumor Marker Industry Chain
Figure 49. Point-of-care Testing (POCT) for Tumor Marker Procurement Model
Figure 50. Point-of-care Testing (POCT) for Tumor Marker Sales Model
Figure 51. Point-of-care Testing (POCT) for Tumor Marker Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Tumor Marker Picture
Figure 2. World Point-of-care Testing (POCT) for Tumor Marker Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Point-of-care Testing (POCT) for Tumor Marker Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 5. World Point-of-care Testing (POCT) for Tumor Marker Average Price (2018-2029) & (US$/Unit)
Figure 6. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Region (2018-2029)
Figure 7. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Region (2018-2029)
Figure 8. North America Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 9. Europe Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 10. China Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 11. Japan Point-of-care Testing (POCT) for Tumor Marker Production (2018-2029) & (K Units)
Figure 12. Point-of-care Testing (POCT) for Tumor Marker Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 15. World Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share by Region (2018-2029)
Figure 16. United States Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 17. China Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 18. Europe Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 19. Japan Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 20. South Korea Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 22. India Point-of-care Testing (POCT) for Tumor Marker Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Point-of-care Testing (POCT) for Tumor Marker by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Point-of-care Testing (POCT) for Tumor Marker Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Point-of-care Testing (POCT) for Tumor Marker Markets in 2022
Figure 26. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Point-of-care Testing (POCT) for Tumor Marker Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 30. China Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Point-of-care Testing (POCT) for Tumor Marker Production Market Share 2022
Figure 32. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Type in 2022
Figure 34. Based on Immunochromatography
Figure 35. Based on Chemiluminescence Technology
Figure 36. Based on Biosensor
Figure 37. Others
Figure 38. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Type (2018-2029)
Figure 39. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Type (2018-2029)
Figure 40. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Point-of-care Testing (POCT) for Tumor Marker Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. lndependent Testing Organization
Figure 45. World Point-of-care Testing (POCT) for Tumor Marker Production Market Share by Application (2018-2029)
Figure 46. World Point-of-care Testing (POCT) for Tumor Marker Production Value Market Share by Application (2018-2029)
Figure 47. World Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Point-of-care Testing (POCT) for Tumor Marker Industry Chain
Figure 49. Point-of-care Testing (POCT) for Tumor Marker Procurement Model
Figure 50. Point-of-care Testing (POCT) for Tumor Marker Sales Model
Figure 51. Point-of-care Testing (POCT) for Tumor Marker Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
